Industry Reports
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E...
Peregrine Pharmaceuticals, Inc announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E Convertible Preferred Stock...
Industry Reports
Merck to Hold Investor Briefing at 2016 ASCO Annual...
Merck known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview of...
Industry Reports
Thunderbolt Pharma, Inc , Vitesse Biologics Company, Acquires Rights...
Baxalta Incorporated , Velocity Pharmaceutical Development, LLC and Astellas Pharma Inc announced that Thunderbolt, Inc., a company established by Vitesse Biologics, acquired all rights to...
Industry Reports
Merck Co Inc Announces Third-Quarter 2016 Dividend
Merck announced that the Board of Directors has declared a quarterly dividend of $0.46 per share of the company’s common stock for the third quarter...
Industry Reports
Merck Increases Sales and Earnings in Q1 Following Sigma-Aldrich...
Healthcare and Life Science drive Group organic sales growth (+4.7%) Sigma-Aldrich acquisition fuels sales (+20.5%) and EBITDA pre exceptionals (+27.0%) Integration of Sigma-Aldrich proceeding...
Industry Reports
Pfizer To Acquire Anacor
Strong fit with Pfizer’s Inflammation and Immunology portfolio Expected to enhance near-term revenue growth for the innovative business Anacor’s flagship asset, crisaborole, has a...
Industry Reports
Stada Arzneimittel AG announces First quarter of 2016 and...
Group sales rise by 2 percent – adjusted by +4 percent Adjusted EBITDA declines slightly by 1 percent Adjusted net income increases by 6...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.